EMEA-000118-PIP02-10-M03

Key facts

Invented name
Orencia
Active substance
Abatacept
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0128/2014
PIP number
EMEA-000118-PIP02-10-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Bristol-Myers Squibb Pharma EEIG

Tel. +44 1895 52 37 40
E-mail: medical.information@bms.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating